PV Bulletin

Regulator

FDA

Track U.S. Food and Drug Administration pharmacovigilance activity in one place: safety communications, medical device recalls, labeling change orders, and postmarketing ICSR standards. PV Bulletin surfaces FDA updates that affect adverse event reporting, the Adverse Event Monitoring System (AEMS), ICH E2B(R3) electronic submissions, and inspection-ready SOP impacts for drug safety teams.

1 update · Sorted by impact priority

publicMedicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA) · United Kingdom · Updated Jun 15, 2026

Unique Liaison Programme between MHRA and FDA

Monitoring

MAHs should prepare for enhanced regulatory collaboration, including potential joint oversight activities and reduced market friction between the UK and US due to closer alignment in regulatory decisions.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only